Zinc for prostate disease and other conditions: a little evidence, a lot of hype, and a significant potential problem.
Study Design
- Loại nghiên cứu
- Review
- Đối tượng nghiên cứu
- Men with prostate conditions
- Can thiệp
- Zinc for prostate disease and other conditions: a little evidence, a lot of hype, and a significant potential problem. Zinc
- Đối chứng
- None
- Kết quả chính
- Prostate conditions
- Xu hướng hiệu quả
- Neutral
- Nguy cơ sai lệch
- Unclear
Abstract
Dietary and supplemental zinc, especially in excess, has received much attention in numerous alternative medicine resources. There is a small amount of medical evidence that zinc may alleviate some mostly rare medical conditions (such as Wilson's disease). However, in prostate conditions, such as BPH, large concentrations of zinc are found in the prostate gland. Excess intake of zinc, especially with individual supplements, has the potential to encourage the growth of prostate conditions from BPH to cancer. In fact, one large study found a significantly higher risk of advanced prostate cancer in men consuming large intakes of these supplements. Large doses of zinc can inhibit the benefits of bisphosphonate drugs, increase testosterone level, increase cholesterol, reduce levels of "good cholesterol" or HDL, and can promote immune dysfunction. More research is needed in this area, but in the meantime, the time seems more than ripe to discourage or immediately discontinue the intake of larger concentrations of zinc for most individuals until adequate research resolves this controversial issue.
Used In Evidence Reviews
Similar Papers
The Journal of nutrition · 2003
Zinc deficiency, infectious disease and mortality in the developing world.
The British journal of nutrition · 2002
The immune system: a target for functional foods?
Journal of the American Society of Nephrology : JASN · 1999
Intake of vitamins B6 and C and the risk of kidney stones in women.
Public health nutrition · 2008
Iron and zinc deficiencies in China: what is a feasible and cost-effective strategy?
CNS drugs · 2022
Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies.
Journal of the American Geriatrics Society · 2011